1. Home
  2. TBLA vs WGS Comparison

TBLA vs WGS Comparison

Compare TBLA & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$4.95

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$60.54

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBLA
WGS
Founded
2007
2017
Country
United States
United States
Employees
2000
1300
Industry
Computer Software: Programming Data Processing
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TBLA
WGS
Price
$4.95
$60.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$5.00
$120.71
AVG Volume (30 Days)
2.7M
647.3K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.63
$29.98
Revenue Next Year
$5.25
$25.92
P/E Ratio
$42.36
$1,251.58
Revenue Growth
N/A
N/A
52 Week Low
$2.84
$32.21
52 Week High
$5.71
$170.87

Technical Indicators

Market Signals
Indicator
TBLA
WGS
Relative Strength Index (RSI) 46.31 47.87
Support Level $3.94 $55.76
Resistance Level $5.18 $63.31
Average True Range (ATR) 0.18 4.10
MACD -0.09 -0.95
Stochastic Oscillator 24.46 21.77

Price Performance

Historical Comparison
TBLA
WGS

About TBLA Taboola.com Ltd.

Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: